Pulmonary disease, chronic obstructive Trials in Spartanburg, United States
Conditions / Pulmonary disease, chronic obstructive / Spartanburg, United States
Research into Pulmonary disease, chronic obstructive spans multiple therapeutic approaches and trial phases.
106 total trials for this combination
Showing top 10 of 106 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02164513 | A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT01313676 | Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 |
| NCT02296138 | Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease. | COMPLETED | PHASE3 |
| NCT00463567 | 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2/PHASE3 |
| NCT00452400 | Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD. | COMPLETED | PHASE2 |
| NCT01126437 | Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 |
| NCT04133909 | Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level | COMPLETED | PHASE3 |
| NCT00862641 | A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE4 |
| NCT00268216 | Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT00157339 | Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD | COMPLETED | PHASE3 |